— e.g. “CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.” (United States)
Frequently asked questions
Is Aurobindo Ranitidine Capsules currently in shortage?
Yes. As of the latest regulator updates, Aurobindo Ranitidine Capsules has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Aurobindo Ranitidine Capsules in shortage?
Regulators attribute the current Aurobindo Ranitidine Capsules shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Aurobindo Ranitidine Capsules shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.